USPTO serial 79454784
Reviewed by CopyMark Law Group
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical and other preparations for medical purposes; pharmaceutical preparations; medical preparations for the treatment and prevention of cancer and autoimmune diseases; biological preparations for medical and pharmaceutical purposes; vaccines; gene therapy products; diagnostic preparations for medical purposes; pharmaceutical preparations for human use; cells for medical use and purposes; pharmaceutical and biological preparations containing and/or for use in cells and cell cultures; cell culture media for medical purposes; biomaterials for medical purposes; chemicals for cell separation and cultivation for medical purposes. | ACTIVE | — |
| 010 | Medical apparatus, articles, equipment and instruments; medical apparatus, articles, equipment and instruments generally used for the diagnosis, treatment or improvement or condition of persons; medical apparatus, articles, equipment and instruments used for cell therapy; medical apparatus, articles, equipment and instruments for use in the administration of pharmaceutical preparations; diagnostic apparatus for medical purposes; drug delivery devices; genetic testing apparatus for medical purposes; testing apparatus for medical purposes; parts, fittings and accessories for all of the above. | ACTIVE | — |
| 042 | Scientific laboratory services; scientific and technological services in the field of biotechnology, pharmaceuticals, medicine and genetics; research, development and testing of pharmaceutical, medical and medicine products; laboratory testing services; clinical trial services; pharmaceutical and medicinal research and development; drug discovery services; scientific research services for medical purposes; culturing of cells for scientific research purposes; pharmaceutical and medical research services; scientific research services; design and development of computer hardware and software for use in the fields of medicine, pharmaceuticals, biotechnology, genetics and clinical trials; human cell research services; information, advice and consultancy in relation to all of the above. | ACTIVE | — |
| 044 | Medical care, including alternative medicine, given by persons or establishments to human beings; medical and healthcare services; medical diagnostic services; medical clinic services and medical analysis services for diagnostic and treatment services provided by medical laboratories; drug screening for medical diagnosis and treatment; health assessment services; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical assistance; medical clinic services; medical equipment rental; medical screening; medical examination; medical treatment using cultured cells; human cell bank services; human cell storage; therapy services; cell bank services for medical transplantation; analysis, processing, removal and treatment of human blood, blood plasma, human cells and bone marrow being medical services; information, advice and consultancy in relation to all of the above. | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 29, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 29, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 26, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 25, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 24, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 23, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 23, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 23, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |